Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sherene Bond

Podiatrist, Foot & Ankle Surgery Cheverly, MD Doctor of Podiatric Medicine

NPI 1396146593 CMS profile 2987693

6124 Landover Rd, Cheverly, MD 20785

Open in the dashboard

General payments

$8,359

199 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sherene Bond of Cheverly, MD is reported in the CMS Open Payments database as having received $8,359 across 199 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,137 47
2024 General $2,381 44
2023 General $1,009 32
2022 General $2,127 43
2021 General $321 18
2020 General $167 10
2019 General $216 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sherene Bond
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Sherene Bond were reported at $2,137. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Sherene Bond Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $216 $389 $118–$1,406 $163
2020 $167 $191 $62–$691 $114
2021 $321 $329 $104–$1,341 $132
2022 $2,127 $419 $125–$1,611 $149
2023 $1,009 $377 $128–$1,164 $160
2024 $2,381 $394 $134–$1,168 $164
2025 $2,137 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supreme Orthopedic Systems, LLC $1,746 8 payments
  2. Smith+Nephew, Inc. $1,220 47 payments
  3. Arthrex, Inc. $1,128 12 payments
  4. Kerecis Limited $1,005 13 payments
  5. MIMEDX Group, Inc. $930 11 payments
  6. AbbVie, Inc. $540 29 payments
  7. Paratek Pharmaceuticals, Inc. $341 20 payments
  8. Organogenesis Inc. $265 10 payments
  9. Stryker Corporation $190 2 payments
  10. Integra LifeSciences Corporation $139 7 payments
  11. Other $855 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,932 195 payments
  2. Travel and Lodging $1,227 3 payments
  3. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis SurgiClose Wound Care $754 10 payments
  2. Kerecis GraftGuide $754 10 payments
  3. Kerecis SurgiClose Wound Care $754 10 payments
  4. Kerecis SurgiClose Wound Care $754 10 payments
  5. Kerecis SurgiClose Wound Care $754 10 payments
  6. DALVANCE $540 29 payments
  7. GRAFIX PL $508 21 payments
  8. NUZYRA $341 20 payments
  9. STRAVIX PL $272 8 payments
  10. Kerecis Omega3 SurgiClose $251 3 payments
  11. Other $4,114 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

118

Median for Podiatry: 160

Drug cost

$11,724

Median for Podiatry: $2,368

Branded share of claims

12.7%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Santyl Collagenase Clostridium Hist. Brand 15 $10,918
Gabapentin Generic 49 $320
Doxycycline Hyclate Generic 20 $225
Triamcinolone Acetonide Generic 11 $149
Ciprofloxacin Hcl Generic 11 $89
Meloxicam Generic 12 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 66 billing codes

Paid by Medicare

$108,923

Medicare's payments for the services billed

Medicare patients

253

Average age 73

Services billed

1,465

141 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 70%
Chronic kidney disease 57%
Arthritis 55%
Ischemic heart disease 40%
Heart failure 36%
Depression 31%
Alzheimer's or dementia 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DALVANCE
$131 — —
NUZYRA
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record